Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 249

1.

Evidence informing the UK's COVID-19 public health response must be transparent.

Alwan NA, Bhopal R, Burgess RA, Colburn T, Cuevas LE, Smith GD, Egger M, Eldridge S, Gallo V, Gilthorpe MS, Greenhalgh T, Griffiths C, Hunter PR, Jaffar S, Jepson R, Low N, Martineau A, McCoy D, Orcutt M, Pankhania B, Pikhart H, Pollock A, Scally G, Smith J, Sridhar D, Taylor S, Tennant PWG, Themistocleous Y, Wilson A; 36 signatories.

Lancet. 2020 Mar 28;395(10229):1036-1037. doi: 10.1016/S0140-6736(20)30667-X. Epub 2020 Mar 17. No abstract available.

PMID:
32197104
2.
3.

Spontaneously occurring cardiovascular lesions in commonly used laboratory animals.

Herman E, Eldridge S.

Cardiooncology. 2019 Jun 3;5:6. doi: 10.1186/s40959-019-0040-y. eCollection 2019. Review.

4.

Improving the healthcare response to domestic violence and abuse in UK primary care: interrupted time series evaluation of a system-level training and support programme.

Sohal AH, Feder G, Boomla K, Dowrick A, Hooper R, Howell A, Johnson M, Lewis N, Robinson C, Eldridge S, Griffiths C.

BMC Med. 2020 Mar 5;18(1):48. doi: 10.1186/s12916-020-1506-3.

5.

Is the R coefficient of interest in cluster randomized trials with a binary outcome?

Mbekwe Yepnang AM, Caille A, Eldridge SM, Giraudeau B.

Stat Methods Med Res. 2020 Jan 23:962280219900200. doi: 10.1177/0962280219900200. [Epub ahead of print] No abstract available.

PMID:
31971088
6.

Improving the relevance of randomised trials to primary care: a qualitative study investigating views towards pragmatic trials and the PRECIS-2 tool.

Forbes G, Loudon K, Clinch M, Taylor SJC, Treweek S, Eldridge S.

Trials. 2019 Dec 11;20(1):711. doi: 10.1186/s13063-019-3812-7.

7.

Considerations for an In Vitro, Cell-Based Testing Platform for Detection of Drug-Induced Inotropic Effects in Early Drug Development. Part 2: Designing and Fabricating Microsystems for Assaying Cardiac Contractility With Physiological Relevance Using Human iPSC-Cardiomyocytes.

Ribeiro AJS, Guth BD, Engwall M, Eldridge S, Foley CM, Guo L, Gintant G, Koerner J, Parish ST, Pierson JB, Brock M, Chaudhary KW, Kanda Y, Berridge B.

Front Pharmacol. 2019 Aug 29;10:934. doi: 10.3389/fphar.2019.00934. eCollection 2019. Review.

8.

Supported accommodation for people with mental health problems: the QuEST research programme with feasibility RCT.

Killaspy H, Priebe S, King M, Eldridge S, McCrone P, Shepherd G, Arbuthnott M, Leavey G, Curtis S, McPherson P, Dowling S.

Southampton (UK): NIHR Journals Library; 2019 Sep.

9.

Contaminant Concentrations in Sediments, Aquatic Invertebrates, and Fish in Proximity to Rail Tracks Used for Coal Transport in the Pacific Northwest (USA): A Baseline Assessment.

Hapke WB, Black RW, Eagles-Smith CA, Smith CD, Johnson L, Ylitalo GM, Boyd D, Davis JW, Eldridge SLC, Nilsen EB.

Arch Environ Contam Toxicol. 2019 Nov;77(4):549-574. doi: 10.1007/s00244-019-00667-0. Epub 2019 Sep 19.

PMID:
31538223
10.

RoB 2: a revised tool for assessing risk of bias in randomised trials.

Sterne JAC, Savović J, Page MJ, Elbers RG, Blencowe NS, Boutron I, Cates CJ, Cheng HY, Corbett MS, Eldridge SM, Emberson JR, Hernán MA, Hopewell S, Hróbjartsson A, Junqueira DR, Jüni P, Kirkham JJ, Lasserson T, Li T, McAleenan A, Reeves BC, Shepperd S, Shrier I, Stewart LA, Tilling K, White IR, Whiting PF, Higgins JPT.

BMJ. 2019 Aug 28;366:l4898. doi: 10.1136/bmj.l4898. No abstract available.

11.

Considerations for an In Vitro, Cell-Based Testing Platform for Detection of Adverse Drug-Induced Inotropic Effects in Early Drug Development. Part 1: General Considerations for Development of Novel Testing Platforms.

Guth BD, Engwall M, Eldridge S, Foley CM, Guo L, Gintant G, Koerner J, Parish ST, Pierson JB, Ribeiro AJS, Zabka T, Chaudhary KW, Kanda Y, Berridge B.

Front Pharmacol. 2019 Aug 9;10:884. doi: 10.3389/fphar.2019.00884. eCollection 2019. Review.

12.

Targeting Glycolysis through Inhibition of Lactate Dehydrogenase Impairs Tumor Growth in Preclinical Models of Ewing Sarcoma.

Yeung C, Gibson AE, Issaq SH, Oshima N, Baumgart JT, Edessa LD, Rai G, Urban DJ, Johnson MS, Benavides GA, Squadrito GL, Yohe ME, Lei H, Eldridge S, Hamre J 3rd, Dowdy T, Ruiz-Rodado V, Lita A, Mendoza A, Shern JF, Larion M, Helman LJ, Stott GM, Krishna MC, Hall MD, Darley-Usmar V, Neckers LM, Heske CM.

Cancer Res. 2019 Oct 1;79(19):5060-5073. doi: 10.1158/0008-5472.CAN-19-0217. Epub 2019 Aug 20.

13.

Brave. Bold. Gold: Athletic Activism and the Realities of Childhood Cancer.

Yamasaki J, Eldridge SS, Estes VM.

Health Commun. 2019 Aug 13:1-4. doi: 10.1080/10410236.2019.1651624. [Epub ahead of print]

PMID:
31407592
14.

A Comparative Review of Chemotherapy-Induced Peripheral Neuropathy in In Vivo and In Vitro Models.

Eldridge S, Guo L, Hamre J 3rd.

Toxicol Pathol. 2020 Jan;48(1):190-201. doi: 10.1177/0192623319861937. Epub 2019 Jul 22.

PMID:
31331249
15.

Evaluating the effectiveness and cost-effectiveness of the Smoking Treatment Optimisation in Pharmacies (STOP) intervention: protocol for a cluster randomised controlled trial.

Sohanpal R, Jumbe S, James WY, Steed L, Yau T, Rivas C, Madurasinghe V, Houlihan C, Berdunisov V, Taylor M, Taylor SJC, Griffiths C, Eldridge S, Walton R.

Trials. 2019 Jun 10;20(1):337. doi: 10.1186/s13063-019-3368-6.

16.

Evaluating NHS Stop Smoking Service engagement in community pharmacies using simulated smokers: fidelity assessment of a theory-based intervention.

Jumbe S, James WY, Madurasinghe V, Steed L, Sohanpal R, Yau TK, Taylor S, Eldridge S, Griffiths C, Walton R.

BMJ Open. 2019 May 19;9(5):e026841. doi: 10.1136/bmjopen-2018-026841.

17.

Feasibility Randomised Trial Comparing Two Forms of Mental Health Supported Accommodation (Supported Housing and Floating Outreach); a Component of the QuEST (Quality and Effectiveness of Supported Tenancies) Study.

Killaspy H, Priebe S, McPherson P, Zenasni Z, McCrone P, Dowling S, Harrison I, Krotofil J, Dalton-Locke C, McGranahan R, Arbuthnott M, Curtis S, Leavey G, MacPherson R, Eldridge S, King M.

Front Psychiatry. 2019 Apr 17;10:258. doi: 10.3389/fpsyt.2019.00258. eCollection 2019.

18.

Predictors of moving on from mental health supported accommodation in England: national cohort study.

Killaspy H, Priebe S, McPherson P, Zenasni Z, Greenberg L, McCrone P, Dowling S, Harrison I, Krotofil J, Dalton-Locke C, McGranahan R, Arbuthnott M, Curtis S, Leavey G, Shepherd G, Eldridge S, King M.

Br J Psychiatry. 2019 May 3:1-7. doi: 10.1192/bjp.2019.101. [Epub ahead of print]

PMID:
31046864
19.

Randomised controlled trial and economic evaluation of a task-based weight management group programme.

McRobbie H, Hajek P, Peerbux S, Kahan BC, Eldridge S, Trépel D, Parrott S, Griffiths C, Snuggs S, Smith KM.

BMC Public Health. 2019 Apr 2;19(1):365. doi: 10.1186/s12889-019-6679-3.

20.

An overview of microplastic and nanoplastic pollution in agroecosystems.

Ng EL, Huerta Lwanga E, Eldridge SM, Johnston P, Hu HW, Geissen V, Chen D.

Sci Total Environ. 2018 Jun 15;627:1377-1388. doi: 10.1016/j.scitotenv.2018.01.341. Epub 2018 Feb 20. Review.

PMID:
30857101
21.

The current use of feasibility studies in the assessment of feasibility for stepped-wedge cluster randomised trials: a systematic review.

Kristunas CA, Hemming K, Eborall H, Eldridge S, Gray LJ.

BMC Med Res Methodol. 2019 Jan 10;19(1):12. doi: 10.1186/s12874-019-0658-3.

22.

Transcriptomic profiles of tissues from rats treated with anticancer drug combinations.

Davis M, Knight E, Eldridge SR, Li J, Bushel PR.

Sci Data. 2019 Jan 8;6:180306. doi: 10.1038/sdata.2018.306.

23.

Case finding and therapy for chronic viral hepatitis in primary care (HepFREE): a cluster-randomised controlled trial.

Flanagan S, Kunkel J, Appleby V, Eldridge SE, Ismail S, Moreea S, Griffiths C, Walton R, Pitt M, Salmon A, Madurasinghe V, Barnes E, Simms E, Agarwal K, Foster GR.

Lancet Gastroenterol Hepatol. 2019 Jan;4(1):32-44. doi: 10.1016/S2468-1253(18)30318-2. Epub 2018 Nov 24.

PMID:
30477810
24.

Testing the effectiveness of REACH Pregnancy Circles group antenatal care: protocol for a randomised controlled pilot trial.

Wiggins M, Sawtell M, Wiseman O, McCourt C, Greenberg L, Hunter R, Eldridge S, Haora P, Kaur I, Harden A.

Pilot Feasibility Stud. 2018 Nov 10;4:169. doi: 10.1186/s40814-018-0361-x. eCollection 2018.

25.

The effects of the London 2012 Olympics and related urban regeneration on physical and mental health: the ORiEL mixed-methods evaluation of a natural experiment.

Cummins S, Clark C, Lewis D, Smith N, Thompson C, Smuk M, Stansfeld S, Taylor S, Fahy A, Greenhalgh T, Eldridge S.

Southampton (UK): NIHR Journals Library; 2018 Nov.

26.

Intervention effect estimates in cluster randomized versus individually randomized trials: a meta-epidemiological study.

Leyrat C, Caille A, Eldridge S, Kerry S, Dechartres A, Giraudeau B.

Int J Epidemiol. 2019 Apr 1;48(2):609-619. doi: 10.1093/ije/dyy229.

27.

Reporting of stepped wedge cluster randomised trials: extension of the CONSORT 2010 statement with explanation and elaboration.

Hemming K, Taljaard M, McKenzie JE, Hooper R, Copas A, Thompson JA, Dixon-Woods M, Aldcroft A, Doussau A, Grayling M, Kristunas C, Goldstein CE, Campbell MK, Girling A, Eldridge S, Campbell MJ, Lilford RJ, Weijer C, Forbes AB, Grimshaw JM.

BMJ. 2018 Nov 9;363:k1614. doi: 10.1136/bmj.k1614. No abstract available.

28.

Role of Mcl-1 in regulation of cell death in human induced pluripotent stem cell-derived cardiomyocytes in vitro.

Guo L, Eldridge S, Furniss M, Mussio J, Davis M.

Toxicol Appl Pharmacol. 2018 Dec 1;360:88-98. doi: 10.1016/j.taap.2018.09.041. Epub 2018 Sep 28.

PMID:
30268579
29.

Developing a framework for the ethical design and conduct of pragmatic trials in healthcare: a mixed methods research protocol.

Taljaard M, Weijer C, Grimshaw JM, Ali A, Brehaut JC, Campbell MK, Carroll K, Edwards S, Eldridge S, Forrest CB, Giraudeau B, Goldstein CE, Graham ID, Hemming K, Hey SP, Horn AR, Jairath V, Klassen TP, London AJ, Marlin S, Marshall JC, McIntyre L, McKenzie JE, Nicholls SG, Alison Paprica P, Zwarenstein M, Fergusson DA.

Trials. 2018 Sep 27;19(1):525. doi: 10.1186/s13063-018-2895-x.

30.

The effect of optimised patient information materials on recruitment in a lung cancer screening trial: an embedded randomised recruitment trial.

Parker A, Knapp P, Treweek S, Madhurasinghe V, Littleford R, Gallant S, Sullivan F, Schembri S, Rick J, Graffy J, Collier DJ, Eldridge S, Kennedy A, Bower P.

Trials. 2018 Sep 18;19(1):503. doi: 10.1186/s13063-018-2896-9.

31.

Cost-effectiveness of a domestic violence and abuse training and support programme in primary care in the real world: updated modelling based on an MRC phase IV observational pragmatic implementation study.

Barbosa EC, Verhoef TI, Morris S, Solmi F, Johnson M, Sohal A, El-Shogri F, Dowrick S, Ronalds C, Griffiths C, Eldridge S, Lewis NV, Devine A, Spencer A, Feder G.

BMJ Open. 2018 Aug 29;8(8):e021256. doi: 10.1136/bmjopen-2017-021256.

32.

Improving the healthcare response to domestic violence and abuse in primary care: protocol for a mixed method evaluation of the implementation of a complex intervention.

Sohal AH, Feder G, Barbosa E, Beresford L, Dowrick A, El-Shogri F, Howell A, Lewis N, Johnson M, Nightingale C, Boomla K, Morris S, Eldridge S, Griffiths C.

BMC Public Health. 2018 Aug 3;18(1):971. doi: 10.1186/s12889-018-5865-z.

33.

A randomised controlled trial is not a pilot trial simply because it uses a surrogate endpoint.

Campbell MJ, Lancaster GA, Eldridge SM.

Pilot Feasibility Stud. 2018 Jul 30;4:130. doi: 10.1186/s40814-018-0324-2. eCollection 2018.

34.

MMP-3 in the peripheral serum as a biomarker of knee osteoarthritis, 40 years after open total knee meniscectomy.

Pengas I, Eldridge S, Assiotis A, McNicholas M, Mendes JE, Laver L.

J Exp Orthop. 2018 Jun 15;5(1):21. doi: 10.1186/s40634-018-0132-x.

35.

Opioid prescribing for chronic musculoskeletal pain in UK primary care: results from a cohort analysis of the COPERS trial.

Ashaye T, Hounsome N, Carnes D, Taylor SJC, Homer K, Eldridge S, Spencer A, Rahman A, Foell J, Underwood MR; COPERS Study Team (ISRCTN 24426731).

BMJ Open. 2018 Jun 6;8(6):e019491. doi: 10.1136/bmjopen-2017-019491.

36.

AntiEpileptic drug Monitoring in PREgnancy (EMPiRE): a double-blind randomised trial on effectiveness and acceptability of monitoring strategies.

Thangaratinam S, Marlin N, Newton S, Weckesser A, Bagary M, Greenhill L, Rikunenko R, D'Amico M, Rogozińska E, Kelso A, Hard K, Coleman J, Moss N, Roberts T, Middleton L, Dodds J, Pullen A, Eldridge S, Pirie A, Denny E, McCorry D, Khan KS.

Health Technol Assess. 2018 May;22(23):1-152. doi: 10.3310/hta22230.

37.

Inclusion and exclusion criteria used in non-specific low back pain trials: a review of randomised controlled trials published between 2006 and 2012.

Amundsen PA, Evans DW, Rajendran D, Bright P, Bjørkli T, Eldridge S, Buchbinder R, Underwood M, Froud R.

BMC Musculoskelet Disord. 2018 Apr 12;19(1):113. doi: 10.1186/s12891-018-2034-6.

38.

Can lay health workers support the management of hypertension? Findings of a cluster randomised trial in South Africa.

Goudge J, Chirwa T, Eldridge S, Gómez-Olivé FXF, Kabudula C, Limbani F, Musenge E, Thorogood M.

BMJ Glob Health. 2018 Feb 15;3(1):e000577. doi: 10.1136/bmjgh-2017-000577. eCollection 2018.

39.

Evaluation of community-level interventions to increase early initiation of antenatal care in pregnancy: protocol for the Community REACH study, a cluster randomised controlled trial with integrated process and economic evaluations.

Sawtell M, Sweeney L, Wiggins M, Salisbury C, Eldridge S, Greenberg L, Hunter R, Kaur I, McCourt C, Hatherall B, Findlay G, Morris J, Reading S, Renton A, Adekoya R, Green B, Harvey B, Latham S, Patel K, Vanlessen L, Harden A.

Trials. 2018 Mar 5;19(1):163. doi: 10.1186/s13063-018-2526-6.

40.

Ethical implications of excessive cluster sizes in cluster randomised trials.

Hemming K, Taljaard M, Forbes G, Eldridge SM, Weijer C.

BMJ Qual Saf. 2018 Aug;27(8):664-670. doi: 10.1136/bmjqs-2017-007164. Epub 2018 Feb 20.

41.

Re-randomization increased recruitment and provided similar treatment estimates as parallel designs in trials of febrile neutropenia.

Kahan BC, Morris TP, Harris E, Pearse R, Hooper R, Eldridge S.

J Clin Epidemiol. 2018 May;97:14-19. doi: 10.1016/j.jclinepi.2018.02.002. Epub 2018 Feb 8.

42.

Mechanically Coupled Reaction-Diffusion Model to Predict Glioma Growth: Methodological Details.

Hormuth DA 2nd, Eldridge SL, Weis JA, Miga MI, Yankeelov TE.

Methods Mol Biol. 2018;1711:225-241. doi: 10.1007/978-1-4939-7493-1_11.

43.

Data sharing in clinical trials - practical guidance on anonymising trial datasets.

Keerie C, Tuck C, Milne G, Eldridge S, Wright N, Lewis SC.

Trials. 2018 Jan 10;19(1):25. doi: 10.1186/s13063-017-2382-9.

44.

The Rare Lesser Metatarsal Bipartite Sesamoid A Case Report.

Hood CR Jr, Miller JR, Eldridge S, Tran M.

J Am Podiatr Med Assoc. 2017 Nov;107(6):548-550. doi: 10.7547/16-114.

PMID:
29252020
45.

Quality of reporting of pilot and feasibility cluster randomised trials: a systematic review.

Chan CL, Leyrat C, Eldridge SM.

BMJ Open. 2017 Nov 8;7(11):e016970. doi: 10.1136/bmjopen-2017-016970. Review.

46.

Determining counselling communication strategies associated with successful quits in the National Health Service community pharmacy Stop Smoking programme in East London: a focused ethnography using recorded consultations.

Rivas C, Sohanpal R, MacNeill V, Steed L, Edwards E, Antao L, Griffiths C, Eldridge S, Taylor S, Walton R.

BMJ Open. 2017 Oct 27;7(10):e015664. doi: 10.1136/bmjopen-2016-015664.

47.

Diagnostic Value of Early Magnetic Resonance Imaging After Acute Lateral Ankle Injury.

Miller JR, Dunn KW, Ciliberti LJ Jr, Eldridge SW, Reed LD.

J Foot Ankle Surg. 2017 Nov - Dec;56(6):1143-1146. doi: 10.1053/j.jfas.2017.05.011.

PMID:
29079231
48.

Metabolic Disruption Early in Life is Associated With Latent Carcinogenic Activity of Dichloroacetic Acid in Mice.

Wehmas LC, DeAngelo AB, Hester SD, Chorley BN, Carswell G, Olson GR, George MH, Carter JH, Eldridge SR, Fisher A, Vallanat B, Wood CE.

Toxicol Sci. 2017 Oct 1;159(2):354-365. doi: 10.1093/toxsci/kfx146.

49.

Equipping community pharmacy workers as agents for health behaviour change: developing and testing a theory-based smoking cessation intervention.

Steed L, Sohanpal R, James WY, Rivas C, Jumbe S, Chater A, Todd A, Edwards E, Macneil V, Macfarlane F, Greenhalgh T, Griffiths C, Eldridge S, Taylor S, Walton R.

BMJ Open. 2017 Aug 11;7(8):e015637. doi: 10.1136/bmjopen-2016-015637.

50.

How to design efficient cluster randomised trials.

Hemming K, Eldridge S, Forbes G, Weijer C, Taljaard M.

BMJ. 2017 Jul 14;358:j3064. doi: 10.1136/bmj.j3064. No abstract available.

Supplemental Content

Loading ...
Support Center